Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 25,618 |
| Other current assets | 50 |
| TOTAL | $25,668 |
| Non-Current Assets | |
| Other Non-Current Assets | 27 |
| TOTAL | $27 |
| Total Assets | $25,741 |
| Liabilities | |
| Current Liabilities | |
| Accrued Expenses | 946 |
| Other current liabilities | 26 |
| TOTAL | $972 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 31,806 |
| TOTAL | $31,806 |
| Total Liabilities | $32,778 |
| Shareholders' Equity | |
| Common Shares | 1 |
| Retained earnings | -17,557 |
| Other shareholders' equity | -44 |
| TOTAL | $-7,037 |
| Total Liabilities And Equity | $25,741 |